The Friends of the ICA in Switzerland, chaired by the dedicated Dr. Ronald Fried, continue to pursue their tireless efforts and to offer generous financial support for ICA cancer research grants. Cancer knows no geographical boundaries and every research breakthrough provides hope for cancer patients in Israel as well as worldwide.
This year, the Friends Group in Switzerland made a particularly significant contribution during ICA trying times, and provided additional funds for financing two ICA outstanding research grants on: "Identification and characterization of proteins involved in DNA repair, via their proteasome mediated degradation" under the direction of Dr. Shay Ben-Aroya of Bar-Ilan University and "The role of the tumor suppressor, Sef, in human epidermal homeostasis and epidermal cancer" under the direction of Professor Dina Ron of the Technion, Israel Institute of Technology.
Four additional research fellowships were funded by our loyal Swiss Friends: "Study of the interaction between the adenovirus E4orf4 protein and the PARP-1 DNA damage sensor" under the direction of Prof. Tamar Kleinberger of the Technion, Israel Institute of Technology, "Enhancing T cell reactivity in adoptive cell therapy of cancer" under the direction of Prof. Gideon Gross of MIGAL - Galilee Research Institute, "Targeting P-TEFb and SEC transcription complexes for treatment of Mixed Lineage Leukemia" under the direction of by Dr. Ran Taube of Ben-Gurion University of the Negev and "Role of the Hippo pathway effectors YAP and TAZ in osteosarcomagenesis" under the direction of Prof. Rami Aqeilan of the Hebrew University of Jerusalem.